Burgundy Asset Management Ltd. Raises Holdings in CME Group Inc. (NASDAQ:CME)

Burgundy Asset Management Ltd. boosted its position in CME Group Inc. (NASDAQ:CME) by 0.6% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 684,245 shares of the financial services provider’s stock after acquiring an additional 3,811 shares during the quarter. Burgundy Asset Management Ltd. owned 0.19% of CME Group worth $134,523,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors have also recently added to or reduced their stakes in CME. B. Riley Wealth Advisors Inc. boosted its stake in CME Group by 1.3% in the fourth quarter. B. Riley Wealth Advisors Inc. now owns 3,625 shares of the financial services provider’s stock valued at $782,000 after acquiring an additional 48 shares during the period. Capital Advisors Ltd. LLC boosted its position in CME Group by 4.3% during the 1st quarter. Capital Advisors Ltd. LLC now owns 1,160 shares of the financial services provider’s stock valued at $250,000 after purchasing an additional 48 shares during the period. Lantz Financial LLC grew its stake in CME Group by 1.1% during the 1st quarter. Lantz Financial LLC now owns 4,561 shares of the financial services provider’s stock worth $982,000 after buying an additional 49 shares during the last quarter. Lester Murray Antman dba SimplyRich increased its position in CME Group by 0.7% in the second quarter. Lester Murray Antman dba SimplyRich now owns 7,667 shares of the financial services provider’s stock worth $1,507,000 after buying an additional 50 shares during the period. Finally, Greystone Financial Group LLC lifted its stake in CME Group by 1.6% in the fourth quarter. Greystone Financial Group LLC now owns 3,282 shares of the financial services provider’s stock valued at $691,000 after buying an additional 52 shares during the last quarter. Hedge funds and other institutional investors own 87.75% of the company’s stock.

Insider Buying and Selling

In other CME Group news, Director Bryan T. Durkin sold 7,593 shares of the company’s stock in a transaction on Friday, August 30th. The stock was sold at an average price of $214.59, for a total value of $1,629,381.87. Following the transaction, the director now owns 55,607 shares of the company’s stock, valued at $11,932,706.13. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. In related news, Director Bryan T. Durkin sold 7,593 shares of CME Group stock in a transaction dated Friday, August 30th. The stock was sold at an average price of $214.59, for a total value of $1,629,381.87. Following the transaction, the director now owns 55,607 shares of the company’s stock, valued at approximately $11,932,706.13. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, CFO Lynne Fitzpatrick sold 754 shares of the business’s stock in a transaction dated Sunday, September 15th. The stock was sold at an average price of $216.99, for a total value of $163,610.46. Following the sale, the chief financial officer now owns 13,261 shares in the company, valued at approximately $2,877,504.39. The disclosure for this sale can be found here. 0.30% of the stock is currently owned by insiders.

CME Group Stock Down 0.9 %

Shares of CME stock opened at $216.30 on Thursday. CME Group Inc. has a 1 year low of $190.70 and a 1 year high of $223.80. The company has a debt-to-equity ratio of 0.10, a quick ratio of 1.02 and a current ratio of 1.02. The business’s fifty day moving average is $207.08 and its 200-day moving average is $207.54. The stock has a market cap of $77.88 billion, a PE ratio of 24.61, a price-to-earnings-growth ratio of 8.85 and a beta of 0.55.

CME Group (NASDAQ:CME) last released its earnings results on Wednesday, July 24th. The financial services provider reported $2.56 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.53 by $0.03. CME Group had a return on equity of 12.82% and a net margin of 56.98%. The firm had revenue of $1.53 billion for the quarter, compared to analyst estimates of $1.53 billion. During the same period in the previous year, the company earned $2.30 earnings per share. CME Group’s revenue was up 12.7% compared to the same quarter last year. Equities analysts expect that CME Group Inc. will post 9.94 earnings per share for the current fiscal year.

CME Group Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, September 25th. Investors of record on Monday, September 9th will be paid a dividend of $1.15 per share. This represents a $4.60 annualized dividend and a yield of 2.13%. The ex-dividend date of this dividend is Monday, September 9th. CME Group’s dividend payout ratio is presently 52.33%.

Analysts Set New Price Targets

Several equities analysts have recently commented on CME shares. JPMorgan Chase & Co. upped their price target on shares of CME Group from $187.00 to $191.00 and gave the stock an “underweight” rating in a research report on Thursday, July 25th. Piper Sandler restated an “overweight” rating and issued a $225.00 price target on shares of CME Group in a research note on Tuesday, August 20th. Barclays lifted their price target on CME Group from $208.00 to $209.00 and gave the company an “equal weight” rating in a report on Thursday, July 25th. Bank of America lowered CME Group from a “neutral” rating to an “underperform” rating and decreased their price objective for the stock from $212.00 to $177.00 in a report on Tuesday, September 3rd. Finally, Deutsche Bank Aktiengesellschaft lifted their target price on CME Group from $193.00 to $200.00 and gave the company a “hold” rating in a research note on Thursday, August 15th. Four investment analysts have rated the stock with a sell rating, five have assigned a hold rating and three have assigned a buy rating to the company. According to MarketBeat.com, CME Group presently has an average rating of “Hold” and a consensus target price of $209.73.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.